1. Home
  2. GCTK vs NUWE Comparison

GCTK vs NUWE Comparison

Compare GCTK & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GlucoTrack Inc.

GCTK

GlucoTrack Inc.

HOLD

Current Price

$3.46

Market Cap

3.4M

Sector

Health Care

ML Signal

HOLD

Logo Nuwellis Inc.

NUWE

Nuwellis Inc.

HOLD

Current Price

$2.10

Market Cap

2.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GCTK
NUWE
Founded
2001
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4M
2.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GCTK
NUWE
Price
$3.46
$2.10
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
161.9K
306.7K
Earning Date
11-13-2025
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$8,167,999.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$10.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.21
$1.71
52 Week High
$133.80
$70.14

Technical Indicators

Market Signals
Indicator
GCTK
NUWE
Relative Strength Index (RSI) 32.98 51.70
Support Level $3.29 $1.72
Resistance Level $4.20 $2.27
Average True Range (ATR) 0.39 0.25
MACD 0.03 0.04
Stochastic Oscillator 10.33 38.25

Price Performance

Historical Comparison
GCTK
NUWE

About GCTK GlucoTrack Inc.

GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.

About NUWE Nuwellis Inc.

Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.

Share on Social Networks: